Artemisinin antimalarials: Preserving the "magic bullet"

Drug Development Research

Volumn 71, Issue 1, 2010, Pages 12-19

  Maude, Richard J ^a,b,c   Woodrow, Charles J ^a,d   White, Lisa J ^a,b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Antimalarial; Artemisinin; Malaria; Resistance

Indexed keywords

AMODIAQUINE; ARTEETHER; ARTEMETHER; ARTEMETHER PLUS BENFLUMETOL; ARTEMISIN; ARTEMISININ; ARTEMISININ DERIVATIVE; ARTESUNATE; CHLOROQUINE; DIHYDROARTEMISININ; ETHER; FANSIDAR; MEFLOQUINE; QUININE;

AFRICA; ANTIMALARIAL ACTIVITY; ANTIMALARIAL DRUG RESISTANCE; ARTEMISIA ANNUA; ASIAN; CAMBODIA; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; HUMAN; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MONOTHERAPY; NONHUMAN; PARASITE; PATIENT COMPLIANCE; PLASMODIUM VIVAX MALARIA; PREVALENCE; QUALITY CONTROL; REVIEW; TREATMENT DURATION;

EID: 76749157867     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20344     Document Type: Review

References (61)

1. Anstey NM, Price RN, White NJ. 2006. Improving the availability of artesunate for treatment of severe malaria. Med J Aust 184:3-4.
2. Artemether-Quinine Meta-analysis Study Group. 2001. A metaanalysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg 95:637-650.
3. Brewer TG, Grate SJ, Peggins JO, Weina PJ, Petras JM, Levine BS, Heiffer MH, Schuster BG. 1994. Fatal neurotoxicity of arteether and artemether. Am J Trop Med Hyg 51:251-259.
4. Burki T. 2009. Artemisinin resistance could endanger fight against malaria. Lancet 9:213.
5. Day N, Dondorp AM. 2007. The management of patients with severe malaria. Am J Trop Med Hyg 77:29-35.
6. Denis MB, Tsuyuoka R, Poravuth Y, Narann TS, Seila S, Lim C, Incardona S, Lim P, Sem R, Socheat D, Christophel EM, Ringwald P. 2006a. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia. Trop Med Int Health 11: 1360-1366.
7. Denis MB, Tsuyuoka R, Lim P, Lindegardh N, Yi P, Top SN, Socheat D, Fandeur T, Annerberg A, Christophel EM, Ringwald P. 2006b. Efficacy of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in northwest Cambodia. Trop Med Int Health 11:1800-1807.
8. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, Petit A, Lynam AJ, Johnson A, Hien TT, McGready R, Farrar JJ, Looareesuwan S, Day NP, Green MD, White NJ. 2004. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 9:1241-1246.
9. Dondorp A, Nosten F, Stepniewska K, Day N, White N, South East Asian Quinine Artesunate Malaria Trial (SEAQUAMAT) group. 2005. Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet 366:717-725.
10. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NPJ, Lindegardh N, Socheat D, White NJ. 2009. Reduced in-vivo susceptibility of Plasmodium falciparum to artesunate in Western Cambodia. N Engl J Med 361:455-467.
11. Falade C, Makanga M, Premji Z, Ortmann CE, Stockmeyer M, de Palacios PI. 2005. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 99:459-467.
12. Fidock DA, Eastman RT, Ward SA, Meshnick SR. 2008. Recent highlights in antimalarial drug resistance and chemotherapy research. Trends Parasitol 24:537-544.
13. Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A, Baiden F, Yunus EB, Binka F, Clerk C, Folb P, Hassan R, Hossain MA, Kimbute O, Kitua A, Krishna S, Makasi C, Mensah N, Mrango Z, Olliaro P, Peto R, Peto TJ, Rahman MR, Ribeiro I, Samad R, White NJ; Study 13 Research Group. 2009. Pre-referral rectal artesunate to prevent death and disability in severe malaria: a placebo-controlled trial. Lancet 373:557-566.
14. Guthmann JP, Ampuero J, Fortes F, van Overmeir C, Gaboulaud V, Tobback S, Dunand J, Saraiva N, Gillet P, Franco J, Denoncin A, van Herp M, Balkan S, Dujardin JC, D'Alessandro U, Legros D. 2005. Antimalarial efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, and the combinations of amodiaquineartesunate and sulfadoxine-pyrimethamine-artesunate in Huambo and Bie provinces, central Angola. Trans R Soc Trop Med Hyg 99:485-492.
15. Haynes RK, Vonwiller SC. 1994. Extraction of artemisinin and artemisinic acid: preparation of artemether and new analogues. Trans R Soc Trop Med Hyg 88:S23-S26.
16. Hien TT. 1994. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam. Trans R Soc Trop Med Hyg 88:S7-S8.
17. Hien TT, White NJ. 1993. Qinghaosu. Lancet 341:603-608.
18. Hsu E. 2006. Reflections on the "discovery" of the antimalarial qinghao. Br J Clin Pharmacol 61:666-670.
19. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, Mercereau-Puijalon O. 2005. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366:1960-1963.
20. Klayman DL, Lin AJ, Acton N, Scovill JP, Hoch JM, Milhous WK, Theoharides AD, Dobek AS. 1984. Isolation of artemisinin (qinghaosu) from Artemisia annua growing in the United States. J Nat Prod 47:715-717.
21. Klayman DL. 1985. Qinghaosu (artemisinin): an antimalarial drug from China. Science 228:1049-1055.
22. Li G-Q, Guo X-B, Fu L-C, Jian H-X, Wang X-H. 1994. Clinical trials of artemisinin and its derivatives in the treatment of malaria in China. Trans R Soc Trop Med Hyg 88:S5-S6.
23. Looareesuwan S. 1994. Overview of clinical studies on artemisinin derivatives in Thailand. Trans R Soc Trop Med Hyg 88(Suppl 1): S9-S11.
24. Maude RJ, Plewes K, Faiz MA, Hanson J, Charunwatthana P, Lee SJ, Tärning J, Yunus EB, Hoque MG, Hasan MU, Hossain A, Lindegardh N, Day NP, White NJ, Dondorp AM. 2009a. Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria? Am J Trop Med Hyg 80:126-132.
25. Maude RJ, Pontavornpinyo W, Saralamba S, Aguas R, Yeung S, Dondorp AM, Day NP, White NJ, White LJ. 2009b. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J 8:31.
26. Maude RJ, Pontavornpinyo W, Saralamba S, Dondorp AM, Day NP, White NJ, White LJ. 2009c. The role of mathematical modelling in malaria elimination and eradication (Comment on: can malaria be eliminated?). Trans R Soc Trop Med Hyg 103:643-644.
27. Mayxay M, Khanthavong M, Lindegårdh N, Keola S, Barends M, Pongvongsa T, Yapom R, Annerberg A, Phompida S, Phetsouvanh R, White NJ, Newton PN. 2004. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic. Clin Infect Dis 39:1139-1147.
28. Mutabingwa TK, Anthony D, Heller A, Hallett R, Ahmed J, Drakeley C, Greenwood BM, Whitty CJ. 2005. Amodiaquine alone, amodiaquine-sulfadoxine- pyrimethamine, amodiaquine-artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365:1474-1480.
29. Nelson R. 2006. WHO requests halt of sales of monotherapy drugs for malaria. Lancet 366:1960-1963.
30. Newton PN, McGready R, Fernandez F, Green MD, Sunjio M, Bruneton C, Phanouvong S, Millet P, Whitty CJM, Talisuna AO, Proux S, Christophel EM, Malenga G, Singhasivanon P, Bojang K, Kaur H, Palmer K, Day NPJ, Greenwood BM, Nosten F, White NJ. 2006. Manslaughter by fake artesunate in asia-will Africa be next? PLOS Med 3:e197.
31. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, Artemisinin Resistance in Cambodia 1 (ARC1) Study Consortium. 2008. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 359:2619-2620.
32. Nosten F, Luxemburger C, ter Kuile FO, Woodrow C, Eh JP, Chongsuphajaisiddhi T, White NJ. 1994. Treatment of multidrugresistant Plasmodium falciparum malaria with 3-day artesunatemefloquine combination. J Infect Dis 170:971-977.
33. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, McGready R, ter Kuile F, Looareesuwan S,White NJ. 2000. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356:297-302.
34. Olliaro P, Wells TNC. 2009. The global portfolio of new antimalarial medicines under development. Clin Pharm Ther 85:584-595.
35. Piola P, Fogg C, Bajunirwe F, Biraro S, Grandesso F, Ruzagira E, Babigumira J, Kigozi I, Kiguli J, Kyomuhendo J, Ferradini L, Taylor W, Checchi F, Guthmann JP. 2005. Supervised versus unsupervised intake of six-dose artemether-lumefantrine for treatment of acute, uncomplicated Plasmodium falciparum malaria in Mbarara, Uganda: a randomised trial. Lancet 365:1467-1473.
36. Pongtavornpinyo W, Hastings IM, Dondorp A, White LJ, Maude RJ, Saralamba S, Day NP, White NJ, Boni MF. 2009. Probability of emergence of antimalarial resistance in different stages of the parasite life cycle. Evol Appl 2:52-61.
37. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364:438-447.
38. Qigui L, Milhous WK, Weina PJ. 2007. Introduction. 1. History of artesunate. Artemisinins in malaria therapy. New York: Nova Medical Books. p 1-9.
39. Qinghaosu Antimalaria Coordinating Research Group. 1979. Antimalarial studies on qinghaosu. Chin Med J 92:811-816.
40. Roll Back Malaria/World Health Organization. 2004. Position of WHO's Roll Back Malaria Department on Malaria Treatment Policy. Statement. http://www.who.int/malaria/docs/who-apt-position.htm [Accessed 1st July 2009].
41. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. 2004. Intercontinental spread of pyrimethamine-resistant malaria. Science 305:1124.
42. Stepniewska K, White NJ. 2008. Pharmacokinetic determinants of the window of selection for antimalarial drug resistance. Antimicrob Agents Chemother 52:1589-1596.
43. Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, Barnes K, Myint HY, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien TT, Farrar J, Nosten F, Day NP, White NJ. 2004. In vivo assessment of antimalarial drug efficacy in falciparum malaria: the duration of follow-up. Antimicrob Agents Chemother 48:4271-4280.
44. Stohrer JM, Dittrich S, Thongpaseuth V, Vanisaveth V, Phetsouvanh R, Phompida S, Monti F, Christophel EM, Lindegardh N, Annerberg A, Jelinek T. 2004. Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic. Trop Med Int Health 9:1175-1183.
45. van den Broek I, Amsalu R, Balasegaram M, Hepple P, Alemu E, Hussein el B, Al-Faith M, Montgomery J, Checchi F. 2005. Efficacy of two artemisinin combination therapies for uncomplicated falciparum malaria in children under 5 years, Malakal, Upper Nile, Sudan. Malar J 4:14.
46. Verdrager J. 1986. Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia. J Trop Med Hyg 89:277-289.
47. Vijaykadga S, Rojanawatsirivej C, Cholpol S, Phoungmanee D, Nakavej A, Wongsrichanalai C. 2006. In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003. Trop Med Int Health 11:211-219.
48. Weina PJ. 2008. Artemisinins from folklore to modern medicine- transforming an herbal extract to life-saving drugs. Parasitologia 50:25-29.
49. White NJ. 2008. Qinghaosu (artemisinin): the price of success. Science 320:330-334.
50. Wilcox M, Bodeker G, Bourdy G, Dhingra V, Falquet J, Ferreira JFS, Graz B, Hirt HM, Hsu E, Melillo de Magalhaes R, Provendier D, Wright CW. 2004. Artemisia annua as a traditional herbal antimalarial. In: Wilcox M, Bodeker G, Rasoanaivo P, editors. Traditional herbal medicines for modern times. Boca Raton, FL: CRC Press. p 43-60.
51. Woodrow CJ, Haynes RK, Krishna S. 2005. Artemisinins. Postgrad Med J 81:71-78.
52. World Health Organization. 2006. WHO guidelines for the treatment of malaria. Geneva, Switzerland: WHO Press.
53. World Health Organization. 2008a. Global antimalarial drug policy database. Available at: http://www.who.int/malaria/amdp/amdp-searo.htm and http://www.who.int/malaria/amdp/amdp-wpro.htm (accessed June 2009).
54. World Health Organization. 2008b. Global malaria control and elimination: report of a meeting on containment of artemisinin tolerance. Geneva, Switzerland.
55. World Health Organization. 2008c. Minutes of an informal consultation on resource mobilization for the containment of artemisinin tolerant malaria on the Cambodia-Thailand border. Regional Office for the Western Pacific, Manila, Philippines.
56. World Health Organization Mekong Malaria Programme. 2008d. Development of a strategy towards elimination of Plasmodium falciparum parasites with altered response to artemisinins. Regional Office for Southeast Asia, New Delhi, India.
57. Wright CW. 2002. Artemisia. Taylor & Francis, Taylor and Francis Group, UK. 18:310.
58. Yang H, Liu D, Yang Y, Fan B, Yang P, Li X, Li C, Dong Y, Yang C. 2003. Changes in susceptibility of Plasmodium falciparum to artesunate in vitro in Yunnan Province, China. Trans R Soc Trop Med Hyg 97:226-228.
59. Yeung S, Van Damme W, Socheat D, White NJ, Mills A. 2008. Access to artemisinin combination therapy for malaria in remote areas of Cambodia. Malar J 7:96.
60. Zhou W-S. 1986. Total synthesis of arteannuin (Quinghaosu) and related compounds. Pure Appl Chem 58:817-824.
61. Zwang J, Ashley EA, Karema C, D'Alessandro U, Smithuis F, Dorsey G, Janssens B, Mayxay M, Newton P, Singhasivanon P, Stepniewska K, White NJ, Nosten F. 2009. Safety and efficacy of dihydroartemisinin-piperaquine in Falciparum malaria: a prospective multi-centre individual patient data analysis. PLoS ONE 4:e6358.